{"id":"nicoderm-patch-first-then-aveva-patch","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Skin irritation at patch site"},{"rate":"5-15","effect":"Headache"},{"rate":"5-10","effect":"Nausea"},{"rate":"3-8","effect":"Dizziness"},{"rate":"5-10","effect":"Sleep disturbances"}]},"_chembl":{"chemblId":"CHEMBL1201180","moleculeType":"Small molecule","molecularWeight":"411.33"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nicoderm patch provides initial nicotine replacement to reduce withdrawal symptoms and cravings during smoking cessation. The Aveva patch (if a follow-up formulation) would continue nicotine delivery at a potentially reduced dose as part of a tapering strategy. This combination approach aims to gradually wean patients off nicotine while maintaining compliance and minimizing relapse.","oneSentence":"A sequential nicotine replacement therapy regimen using transdermal patches to deliver nicotine and support smoking cessation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:57:11.145Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Smoking cessation"}]},"trialDetails":[{"nctId":"NCT02371850","phase":"PHASE4","title":"Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2014-10","conditions":"Smoking","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Brand name nicotine patch first, then generic nicotine patch"],"phase":"marketed","status":"active","brandName":"Nicoderm patch first, then Aveva patch","genericName":"Nicoderm patch first, then Aveva patch","companyName":"University of Maryland, Baltimore","companyId":"university-of-maryland-baltimore","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A sequential nicotine replacement therapy regimen using transdermal patches to deliver nicotine and support smoking cessation. Used for Smoking cessation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}